A recent Rutgers School of Public Health and Rutgers Cancer Institute of New Jersey study, led by Dr. Jennifer Tsui, examines the outcomes of patients in Medicaid diagnosed with breast, colorectal, or invasive cervical cancer.
The researchers conducted a retrospective cohort study examining 19,209 total cancer cases, of which 3,253 were Medicaid-linked cases, using information from the New Jersey State Cancer Registry and Medicaid claims.
The authors, who include Rutgers School of Public Health professor, Dr. Antoinette M. Stroup, and collaborators from the Rutgers Center for State Health Policy, found that Medicaid cases were more likely to be diagnosed at a late stage and to experience treatment delays in comparison with non‐Medicaid cases. Newly enrolled Medicaid cases, in particular, had worse outcomes. Engagement with primary care and Medicaid enrollment characteristics, including the length of enrollment and coverage through managed care (MC) versus fee for service (FFS), can drive variations in cancer care delivery and outcomes for the Medicaid population.
“Targeted strategies to enhance care continuity, including access to primary care providers before the diagnosis and a better understanding of pathways to cancer care upon Medicaid enrollment, are needed to improve outcomes in this vulnerable population,” says Dr. Tsui.Tags: Friday Letter Submission